Alpha 2.0
Login Register
» Authors » Angelica Dominguez

Angelica Dominguez

Explore the profile of Angelica Dominguez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 38
Citations 270
Followers 0
Related Specialties
General Medicine
Pediatrics
Infectious Diseases
Top 10 Co-Authors
Francisco Mardones
Pilar Arnaiz
Marcelo Farias
Salesa Barja
Oscar Castillo
Jose L Tapia
Luis Villarroel
Susan M Bueno
Alexis M Kalergis
Pablo A Gonzalez
Published In
Rev Med Chil
Nutr Hosp
J Pediatr Gastroenterol Nutr
Arch Argent Pediatr
BMC Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Past trends and future projections of palliative care needs in Chile: analysis of routinely available death registry and population data
Leniz J, Dominguez A, Bone A, Etkind S, Perez-Cruz P, Sleeman K
BMC Med . 2024 Sep; 22(1):350. PMID: 39218926
Background: The number of people with palliative care needs is projected to increase globally. Chile has recently introduced legislation for universal access to palliative care services for patients with severe...
2.
[Rehospitalization of preterm infants below 32 weeks of gestational age in the first 2 years post discharge]
Pittaluga E, DApremont I, Zamorano A, Dominguez A, Vasquez I, Musalem C
Andes Pediatr . 2024 Aug; 95(3):287-296. PMID: 39093214
Objective: To describe the frequency and characteristics of readmissions in preterm infants younger than 32 weeks of GA or weighing less than 1500 g (< 32w/< 1500 g) at 2...
3.
Asymptomatic herpes simplex virus brain infection elicits cellular senescence phenotypes in the central nervous system of mice suffering multiple sclerosis-like disease
Duarte L, Villalobos V, Farias M, Rangel-Ramirez M, Gonzalez-Madrid E, Navarro A, et al.
Commun Biol . 2024 Jul; 7(1):811. PMID: 38965360
Experimental autoimmune encephalomyelitis (EAE) is a demyelinating disease affecting the central nervous system (CNS) in animals that parallels several clinical and molecular traits of multiple sclerosis in humans. Herpes simplex...
4.
Growth patterns in infants born to women with pregestational overweight/obesity supplemented with docosahexaenoic acid during pregnancy
De Toro V, Alberti G, Dominguez A, Carrasco-Negue K, Ferrer P, Valenzuela R, et al.
J Pediatr Gastroenterol Nutr . 2024 Jun; 79(2):371-381. PMID: 38922906
Background: Previous studies of maternal docosahexaenoic acid (DHA) supplementation during pregnancy have controversial and contrasting results on the short and long-term effects on early child growth. The impact of this...
5.
Spatio-temporal distribution of hospitalizations for chronic Chagas disease and risk factors associated with in-hospital mortality and surgical intervention in Chile
Atero N, Torres M, Dominguez A, Diethelm-Varela B, Cordova-Buhrle F, Mardones F
PLoS Negl Trop Dis . 2024 Apr; 18(4):e0012124. PMID: 38662649
Chagas disease (CD) is a neglected parasitic zoonotic disease that affects over 6 million people worldwide. We conducted a retrospective study to analyze the spatiotemporal trends and risk factors for...
6.
"Appagalo" a Customized Mobile Health Intervention (mHealth) for Smoking Cessation in Women: A Randomized Controlled Trial
Martinez-Gutierrez J, Dominguez A, Lopez C, Alcantara J, Althausen C, Rojas M, et al.
Tob Use Insights . 2023 Feb; 16:1179173X231152316. PMID: 36844174
Background: Almost 30% of Chilean women report cigarette smoking with important repercussions on their health. Objective: Design and test a mobile phone intervention for smoking cessation in young women. Study...
7.
Secondary respiratory early and late infections in mechanically ventilated patients with COVID-19
Ceballos M, Nunez C, Uribe J, Vera M, Castro R, Garcia P, et al.
BMC Infect Dis . 2022 Sep; 22(1):760. PMID: 36175841
Background: Patients with COVID-19 receiving mechanical ventilation may become aggravated with a secondary respiratory infection. The aim of this study was to describe secondary respiratory infections, their predictive factors, and...
8.
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial
Abarca K, Iturriaga C, Urzua M, Le Corre N, Pineda A, Fernandez C, et al.
Vaccines (Basel) . 2022 Jul; 10(7). PMID: 35891246
Several vaccines have been developed to control the COVID-19 pandemic. CoronaVac, an inactivated SARS-CoV-2 vaccine, has demonstrated safety and immunogenicity, preventing severe COVID-19 cases. We investigate the safety and non-inferiority...
9.
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial
Bueno S, Abarca K, Gonzalez P, Galvez N, Soto J, Duarte L, et al.
medRxiv . 2022 Apr; PMID: 35441164
Background: The ongoing COVID-19 pandemic has had a significant impact worldwide, with an incommensurable social and economic burden. The rapid development of safe and protective vaccines against this disease is...
10.
Growth of Very Low Birth Weight Infants Who Received a Liquid Human Milk Fortifier: A Randomized, Controlled Multicenter Trial
Masoli D, Mena P, Dominguez A, Ramolfo P, Vernal P, Pantoja M, et al.
J Pediatr Gastroenterol Nutr . 2021 Oct; 74(3):424-430. PMID: 34620759
Objectives: To evaluate growth (weight, length, head circumference, and knee-heel length [KHL]) in very low birth weight (VLBW) infants (500-1500 g) who received human milk with a liquid fortifier (LHMF)...